R250P (p.Arg250Pro) variant of GCK (Hexokinase-4)

R250P (p.Arg250Pro) in GCK (Hexokinase-4) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as uncertain significance in the context of Monogenic diabetes. The available variant effect predictions contribute to a CATVariant prioritization score of 0.65 / 1. The record also includes structural context.

R250P (p.Arg250Pro) variant details